Mark E. Schneiderhan, PharmD, BCPP
University of Minnesota College of Pharmacy, Department of Pharmacy Practice and Pharmaceutical Sciences, Duluth, Minnesota; Human Development Center, Department of Psychiatry, Duluth, Minnesota; Mark E. Schneiderhan, PharmD, BCPP, University of Minnesota—Duluth, Department of Pharmacy Practice and Pharmaceutical Sciences, 232 Life Science 1110 Kirby Drive, Duluth, Minnesota 55812-3003 ([email protected]).
Original Research
Observed Sex Differences in Cardiometabolic Indices in Patients on Antipsychotics
April 8, 2021
Recognition of sex differences can promote a more personalized patient-centered care approach to ensure goals of therapy are achieved among patients prescribed antipsychotics. Read on to find out more.
Article
Twelve-Month Prospective Randomized Study of Pharmacists Utilizing Point-Of-Care Testing for Metabolic Syndrome and Related Conditions in Subjects Prescribed Antipsychotics
October 15, 2014
To address the gaps in metabolic monitoring, a prospective study of 120 subjects was conducted in three community mental health settings to primarily see if point-of-care testing of lipids,...
